Possible cefotaxime-induced Stevens-Johnson syndrome

Annals of Pharmacotherapy

Volumn 37, Issue 6, 2003, Pages 812-814

  Liberopoulos, Evagelos N ^a   Liamis, George L ^a   Elisaf, Moses S ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Cefotaxime; Erythema multiforme; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

CEFOTAXIME;

AGED; ARTICLE; BLISTER; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; HUMAN; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; URINARY TRACT INFECTION;

AGED; CEFOTAXIME; FEMALE; HUMANS; STEVENS-JOHNSON SYNDROME;

EID: 0037809604     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C453     Document Type: Article

References (11)

1. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau J-C. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129: 92-6.
2. Roujeau J-C, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
3. Roujeau J-C, Stern RS. Severe cutaneous adverse reactions to drugs. N Engl J Med 1994;331:1272-85.
4. Yetiv JZ, Bianchine JR, Owen JA Jr. Etiologic factors of the Stevens-Johnson syndrome. South Med J 1980;73:599-602.
5. Murray KM, Camp MS. Cephalexin-induced Stevens-Johnson syndrome. Ann Pharmacother 1992;26:1230-3.
6. McArthur JE, Dyment PG. Stevens-Johnson syndrome with hepatitis following therapy with ampicillin and cephalexin. N Z Med J 1975;81: 390-2.
7. Kelkar PS, Li JT-C. Cephalosporin allergy. N Engl J Med 2001;345:804-9.
8. Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online 2002;8:5.
9. Green ST, Natarajan S, Campbell JC. Erythema multiforme following cefotaxime therapy (letter). Postgrad Med J 1986;62:415.
10. Arellano F, Sacristan JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993;27:337-43.
11. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.